http://orcid.org/0000-0002-0019-5333
Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ikko Tomisaki, Hirofumi Ikuta, Katsuyoshi Higashijima, Rei Onishi, Akinori Minato & Naohiro Fujimoto. (2019) Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution. Cancer Investigation 37:10, pages 524-530.
Read now
Read now
Articles from other publishers (16)
William A. Weston & Alexis R. Barr. (2023) A cell cycle centric view of tumour dormancy. British Journal of Cancer 129:10, pages 1535-1545.
Crossref
Crossref
Oliver Best, Ashan Canagasingham, Zhixin Liu, Paul Doan, Anne-Maree Haynes, Warick Delprado, Fiona Maclean, Carlo Yuen, Phillip Stricker & James Thompson. (2023) Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy. Pathology 55:4, pages 492-497.
Crossref
Crossref
Sarina Cameron, Genevieve Deblois, James R. Hawley, Aditi Qamra, Stanley Zhou, Seyed Ali Madani Tonekaboni, Alexander Murison, Romy Van Vliet, Juan Liu, Jason W. Locasale & Mathieu Lupien. (2023) Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer. Oncogene 42:21, pages 1693-1703.
Crossref
Crossref
Mats Steinholtz Ahlberg, Hans Garmo, Hans-Olov Adami, Ove Andrén, Jan-Erik Johansson, Gunnar Steineck, Lars Holmberg & Anna Bill-Axelson. (2022) Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study. BMJ Open 12:12, pages e057242.
Crossref
Crossref
Kratika Yadav, Mena Asha Krishnan & Venkatesh Chelvam. (2022)
In Vitro
and
In Vivo
Evaluation of Targeted Fluorescent Imaging Agents for Diagnosis and Resection of Cancer
. Current Protocols 2:12.
Crossref
Crossref
Katharina Beyer, Vera Straten, Sebastiaan Remmers, Steven MacLennan, Sara MacLennan, Giorgio Gandaglia, Peter-Paul M. Willemse, Ronald Herrera, Muhammad Imran Omar, Beth Russell, Johannes Huber, Markus Kreuz, Alex Asiimwe, Tom Abbott, Alberto Briganti, Mieke Van Hemelrijck & Monique J. Roobol. (2022) Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform. Journal of Personalized Medicine 12:5, pages 751.
Crossref
Crossref
Matteo Ferro, Ottavio de Cobelli, Gennaro Musi, Francesco del Giudice, Giuseppe Carrieri, Gian Maria Busetto, Ugo Giovanni Falagario, Alessandro Sciarra, Martina Maggi, Felice Crocetto, Biagio Barone, Vincenzo Francesco Caputo, Michele Marchioni, Giuseppe Lucarelli, Ciro Imbimbo, Francesco Alessandro Mistretta, Stefano Luzzago, Mihai Dorin Vartolomei, Luigi Cormio, Riccardo Autorino & Octavian Sabin Tătaru. (2022) Radiomics in prostate cancer: an up-to-date review. Therapeutic Advances in Urology 14, pages 175628722211090.
Crossref
Crossref
Beáta Zs. Kovács, László G. Puskás, Lajos I. Nagy, András Papp, Zoltán Gyöngyi, István Fórizs, György Czuppon, Ildikó Somlyai & Gábor Somlyai. (2022) Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients. Cancer Control 29, pages 107327482110689.
Crossref
Crossref
Frederik B. Thomsen, Hans Garmo, Klaus Brasso, Lars Egevad & Pär Stattin. (2021) Temporal changes in cause‐specific death in men with localised prostate cancer treated with radical prostatectomy: a population‐based, nationwide study. Journal of Surgical Oncology 124:5, pages 867-875.
Crossref
Crossref
Paulius Bosas, Gintaras Zaleskis, Daiva Dabkevičiene, Neringa Dobrovolskiene, Agata Mlynska, Renatas Tikuišis, Albertas Ulys, Vita Pašukoniene, Sonata Jarmalaitė & Feliksas Jankevičius. (2021) Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients. Journal of Clinical Medicine 10:16, pages 3709.
Crossref
Crossref
Axel Heidenreich. (2021) Still Unanswered: The Role of Extended Pelvic Lymphadenectomy in Improving Oncological Outcomes in Prostate Cancer. European Urology 79:5, pages 605-606.
Crossref
Crossref
T. Culty, A. Goujon, G. Defortescu, T. Bessede, F. Kleinclauss, R. Boissier, S. Drouin, J. Branchereau, A. Doerfler, T. Prudhomme, X. Matillon, G. Verhoest, X. Tillou, G. Ploussard, F. Rozet, A. Méjean & M.-O. Timsit. (2021) Recommandations françaises du Comité de transplantation de l’Association française d’urologie (CTAFU) : cancer de la prostate localisé chez le patient transplanté rénal ou en attente de transplantation. Progrès en Urologie 31:1, pages 4-17.
Crossref
Crossref
Felix Preisser, Matthew R. Cooperberg, Juanita Crook, Felix Feng, Markus Graefen, Pierre I. Karakiewicz, Laurence Klotz, Rodolfo Montironi, Paul L. Nguyen & Anthony V. D’Amico. (2020) Intermediate-risk Prostate Cancer: Stratification and Management. European Urology Oncology 3:3, pages 270-280.
Crossref
Crossref
Saira Khan, Shivani Thakkar & Bettina Drake. (2019) Smoking history, intensity, and duration and risk of prostate cancer recurrence among men with prostate cancer who received definitive treatment. Annals of Epidemiology 38, pages 4-10.
Crossref
Crossref
Lorenzo Tosco, Annouschka Laenen, Thomas Gevaert, Isabelle Salmon, Christine Decaestecker, Elai Davicioni, Christine Buerki, Frank Claessens, Johan Swinnen, Karolien Goffin, Raymond Oyen, Wouter Everaerts, Lisa Moris, Gert De Meerleer, Karin Haustermans & Steven Joniau. (2018) Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial. BMC Cancer 18:1.
Crossref
Crossref
Saira Khan, Veronica Hicks, Danielle Rancilio, Marvin Langston, Katina Richardson & Bettina F. Drake. (2018) Predictors of Follow-Up Visits Post Radical Prostatectomy. American Journal of Men's Health 12:4, pages 760-765.
Crossref
Crossref